Seminars in Hematology
Volume 41, Issue 1 , Pages 83-89 , January 2004

Severe ADAMTS-13 deficiency in childhood

  • Reinhard Schneppenheim

      Affiliations

    • Corresponding Author InformationAddress correspondence to Reinhard Schneppenheim, MD, PhD, University Hospital Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistrasse 52, D-20246 Hamburg, Germany
    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Ulrich Budde

      Affiliations

    • Lab Association Prof. Arndt and Partners, Coagulation Laboratory, Hamburg, Germany
    • ,
  • Wolf Hassenpflug

      Affiliations

    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Tobias Obser

      Affiliations

    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

References 

  1. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura (Report of 16 cases and review of the literature). Medicine. 1966;45:139–159
  2. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries (A hitherto undescribed disease). Proc NY Pathol Soc. 1924;24:21–24
  3. Dacie JV, Mollison PL, Richardson N, Selwyn JG, Shapiro L. Atypical congenital haemolytic anemia. Q J Med. 1953;22:79–98
  4. Schulman I, Pierce M, Lukens A, Currimbhoy Z. Studies on thrombopoiesis (I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency). Blood. 1960;16:943–957
  5. Wallace DC, Lovric A, Clubb JS, Carseldine DB. Thrombotic thrombocytopenic purpura in four siblings. Am J Med. 1975;58:724–734
  6. Upshaw JD. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med. 1978;298:1350–1352
  7. Shinohara T, Miyamura S, Suzuki E, Kobayashi K. Congenital microangiopathic hemolytic anemia (Report of a Japanese girl). Eur J Pediatr. 1982;138:191–193
  8. Kirchner KA, Smith RM, Gockerman JP, Luke RG. Hereditary thrombotic thrombocytopenic purpura (Microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations). Nephron. 1982;30:28–30
  9. Merrill RH, Knupp CL, Jennette JC. Familial thrombotic microangiopathy. Q J Med. 1985;57:749–759
  10. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al.  Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307:1432–1435
  11. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87:4223–4234
  12. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87:4235–4244
  13. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA. 1990;87:6306–6310
  14. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98:1654–1661
  15. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001;98:1662–1666
  16. Soejima K, Mimura N, Hirashima M, Maeda H, Hamamoto T, Nakagaki T, et al.  A novel human metalloprotease synthesized in the liver and secreted into the blood (Possibly, the von Willebrand factor-cleaving protease?). J Biochem. 2001;130:475–480
  17. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276:41059–41063
  18. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494
  19. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98:2730–2735
  20. Loof AH, van Vliet HH, Kappers-Klunne MC. Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura. Br J Haematol. 2001;112:1087–1088
  21. Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica. 2003;88:454–458
  22. Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica. 2003;88:914–918
  23. Schneppenheim R, Budde U, Oyen F, Angerhaus D, Aumann V, Drewke E, et al.  von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood. 2003;101:1845–1850
  24. Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, et al.  Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr. 2003;142:310–317
  25. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor (Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)). J Clin Invest. 1986;77:947–951
  26. Assink K, Schiphorst R, Allford S, Karpmann D, Etzioni A, Brichard B, et al.  Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney Int. 2003;63:1995–1999
  27. Schneppenheim R, Angerhaus D, Obser T, Oyen F, Scheiflinger F, Budde U: Dissecting the molecular mechanism of ADAMTS13 deficiency by expression of recombinant protein. Blood Suppl (in press)
  28. Furlan M, Robles R, Morselli B, Sandoz P, Lämmle B. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1999;81:8–13
  29. Kentouche K, Budde U, Furlan M, Scharfe V, Schneppenheim R, Zintl F. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma. Acta Paediatr. 2002;91:1056–1059

PII: S0037-1963(03)00273-7

doi: 10.1053/j.seminhematol.2003.10.007

Seminars in Hematology
Volume 41, Issue 1 , Pages 83-89 , January 2004

Article Tools

* Image Usage & Resolution